Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €129.80 | €137.63 | 6.035% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €91.50 | €95.79 | 4.693% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.93 | €22.78 | 108.374% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €22.15 | €26.01 | 17.410% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €42.20 | €82.93 | 96.519% |
| United Therapeutics | 15 | 0 | 0 | 0 | €219.10 | €289.92 | 32.323% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €156.25 | €215.54 | 37.944% |
| Amedisys Inc. | 13 | 0 | 2 | 0 | €84.00 | €92.26 | 9.833% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €69.00 | €86.72 | 25.677% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.53 | €54.21 | 48.398% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €156.80 | €182.96 | 16.684% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €343.20 | €359.93 | 4.876% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €371.80 | €421.61 | 13.396% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €223.70 | €247.61 | 10.687% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €112.00 | €116.50 | 4.014% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €59.50 | €75.80 | 27.395% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €17.20 | €31.74 | 84.529% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €78.50 | €97.90 | 24.716% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €364.50 | €369.72 | 1.433% |
| Masimo Corp. | 7 | 1 | 3 | 0 | €130.05 | €147.62 | 13.507% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €76.84 | €85.68 | 11.510% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €28.40 | €32.49 | 14.417% |
| Chemed Corp. | 4 | 0 | 0 | 0 | €560.00 | €588.14 | 5.025% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €92.00 | €124.85 | 35.704% |
| Select Medical Holdings | 3 | 0 | 1 | 0 | €25.80 | €36.41 | 41.110% |